Needle-free Drug Delivery Devices Market by Product and Geography - Forecast and Analysis 2020-2024

Global Needle-Free Drug Delivery Devices Market

About this market

Technavio’s needle-free drug delivery devices market analysis considers sales from inhalers, transdermal patches, and jet injectors. Our study also finds the sales of needle-free drug delivery devices in Asia, Europe, North America, and ROW. In 2019, the inhalers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high incidence of asthma will play a significant role in the inhalers segment to maintain its market position. Also, our global needle-free drug delivery devices market report looks at factors such as the increasing prevalence of chronic disease, rising number of new product launches, and the growing number of strategic alliances. However, frequent product recalls, stringent regulations associated with drug-device combination products, and high costs associated with needle-free drug delivery devices may hamper the growth of the needle-free drug delivery devices industry over the forecast period.

Global Needle-Free Drug Delivery Devices Market

Overview

Increasing prevalence of chronic diseases

Chronic diseases such as diabetes, especially type 1 diabetes is on the rise. According to the OECD, in 2017, about 600 children per 100,000 children had type 1 diabetes in Finland. With growing pollution and respiratory infections, instances of asthma have also dramatically increased. Physicians use needle-free drug delivery devices to administer insulin to children with type 1 diabetes. These devices also prove to be quite effective in the immediate administration of asthmatic medications. Needle-free drug delivery devices administer drugs through the skin of patients either by using shock waves or as a pressure generated by gas or electrophoresis. With the increasing prevalence of various chronic diseases such as diabetes and asthma, the need for needle-free drug delivery devices is increasing, which will lead to the expansion of the global needle-free drug delivery devices market at a CAGR of over 4% during the forecast period.

Technological advances in needle-free drug delivery devices

The intense competition in the market is compelling vendors to invest in R&D to expand their product portfolios. They are developing innovative and advanced devices to administer regular medications for disease management. These devices facilitate the process of drug administration for the management of several diseases and health conditions. The integration of software with needle-free drug delivery devices helps patients to adhere to their regular regimen of medication and, at the same, allows physicians to analyze the condition of their patients and improve the management of chronic respiratory diseases, such as asthma. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global needle-free drug delivery devices market during the forecast period 2020-2024, click here.

Competitive Landscape

With the presence of several major players, the global needle-free drug delivery devices market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading needle-free drug delivery devices manufacturers, that include 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.

Also, the needle-free drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global healthcare equipment market
      • Table Segments of global healthcare equipment market
    • Market characteristics
      • Table Market characteristics
    • Value chain analysis
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Vendors: Key offerings
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2019
      • Table Market size 2019
    • Market size and forecast 2019-2024
      • Table Global market: Size and forecast 2019-2024 ($ millions)
      • Table Global market: Year-over-year growth 2020-2024 (%)
    • Market outlook
  • Five forces analysis
    • Table Five forces analysis 2019
    • Table Five forces analysis 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market segmentation by product
    • Table Product - Market share 2019-2024 (%)
    • Comparison by product
      • Table Comparison by product
    • Inhalers - Market size and forecast 2019-2024
      • Table Inhalers - Market size and forecast 2019-2024 ($ millions)
      • Table Rate of hospital admissions for asthma and COPD (number of people per 100,000 population)
      • Table Inhalers - Year-over-year growth 2020-2024 (%)
    • Transdermal patches - Market size and forecast 2019-2024
      • Table Transdermal patches - Market size and forecast 2019-2024 ($ millions)
      • Table Transdermal patches - Year-over-year growth 2020-2024 (%)
    • Jet injectors - Market size and forecast 2019-2024
      • Table Jet injectors - Market size and forecast 2019-2024 ($ millions)
      • Table Jet injectors - Year-over-year growth 2020-2024 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019-2024
      • Table North America - Market size and forecast 2019-2024 ($ millions)
      • Table North America - Year-over-year growth 2020-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ millions)
      • Table Europe - Year-over-year growth 2020-2024 (%)
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ millions)
      • Table Asia - Year-over-year growth 2020-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ millions)
      • Table ROW - Year-over-year growth 2020-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Estimated cases of children with type 1 diabetes 2017 (per 100,000 children)
      • Table Product launch
      • Table Strategic alliances
    • Market challenges
      • Table Product recalls
      • Table Impact of drivers and challenges
  • Market trends
    • Technological advances in needle-free drug delivery devices
    • Research and funding for development of needle-free drug delivery devices
    • Increasing government initiatives
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • 3M Co.
      • Table 3M Co. - Vendor overview
      • Table 3M Co. - Business segments
      • Table 3M Co. - Organizational developments
      • Table 3M Co. - Geographic focus
      • Table 3M Co. - Segment focus
      • Table 3M Co. - Key offerings
      • Table 3M Co. - Key customers
    • Antares Pharma Inc.
      • Table Antares Pharma Inc. - Vendor overview
      • Table Antares Pharma Inc. - Business segments
      • Table Antares Pharma Inc. - Organizational developments
      • Table Antares Pharma Inc. - Geographic focus
      • Table Antares Pharma Inc. - Key offerings
      • Table Antares Pharma Inc. - Key customers
    • Becton, Dickinson and Co.
      • Table Becton, Dickinson and Co. - Vendor overview
      • Table Becton, Dickinson and Co. - Business segments
      • Table Becton, Dickinson and Co. - Organizational developments
      • Table Becton, Dickinson and Co. - Geographic focus
      • Table Becton, Dickinson and Co. - Segment focus
      • Table Becton, Dickinson and Co. - Key offerings
      • Table Becton, Dickinson and Co. - Key customers
    • Enesi Pharma Ltd.
      • Table Enesi Pharma Ltd. - Vendor overview
      • Table Enesi Pharma Ltd. - Business segments
      • Table Enesi Pharma Ltd. - Organizational developments
      • Table Enesi Pharma Ltd. - Key offerings
      • Table Enesi Pharma Ltd. - Key customers
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Vendor overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Organizational developments
      • Table GlaxoSmithKline Plc - Geographic focus
      • Table GlaxoSmithKline Plc - Segment focus
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Key customers
    • Inovio Pharmaceuticals Inc.
      • Table Inovio Pharmaceuticals Inc. - Vendor overview
      • Table Inovio Pharmaceuticals Inc. - Business segments
      • Table Inovio Pharmaceuticals Inc. - Organizational developments
      • Table Inovio Pharmaceuticals Inc. - Key offerings
      • Table Inovio Pharmaceuticals Inc. - Key customers
    • Mylan NV
      • Table Mylan NV - Vendor overview
      • Table Mylan NV - Product segments
      • Table Mylan NV - Organizational developments
      • Table Mylan NV - Geographic focus
      • Table Mylan NV - Segment focus
      • Table Mylan NV - Key offerings
      • Table Mylan NV - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • PharmaJet Inc.
      • Table PharmaJet Inc. - Vendor overview
      • Table PharmaJet Inc. - Business segments
      • Table PharmaJet Inc. - Organizational developments
      • Table PharmaJet Inc. - Key offerings
      • Table PharmaJet Inc. - Key customers
    • Valeritas Holdings Inc.
      • Table Valeritas Holdings Inc. - Vendor overview
      • Table Valeritas Holdings Inc. - Business segments
      • Table Valeritas Holdings Inc. - Organizational developments
      • Table Valeritas Holdings Inc. - Key offerings
      • Table Valeritas Holdings Inc. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook